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Abstract
Background: To determine radiological features of arthropathy in systemic sclerosis patients with
polyarthritis.
Results: Forty one women and 5 men were included in this study. The mean age was 41 + 14,2
years, the mean duration of disease was 10,5+ 6,5 years. Thirty seven patients (80%) had
radiological abnormalities including joint space narrowing (37%) and erosions (43%). At
presentation, the prevalence of radiological foot abnormalities was lower than that of hands (26%
vs 79%, p < 0,001). There was no significant difference between patients with (n = 24) and without
erosive arthropathy (Joint space narrowing and/or erosion) (n = 22) in terms of cutaneous subtype,
organ involvement, calcinosis presence of rheumatoid factor, ANA, Anti-topoisomerase
antibodies.
Conclusion: This study showed an high frequency of erosive arthropathy in our morroccan SSc
patients with clinical synovitis.
Background
Systemic sclerosis (SSc) is a connective tissue disease char-
acterized by vascular involvement and fibrotic changes in
the skin and internal organs. Joint symptoms have been
noted in 12 to 66% of patients at the time of diagnosis
and in 24 to 97% of patients at some time during the
course of their illness [1]. Many radiological changes in
the joints of SSc patients have been identified but erosive
arthropathy is considered uncommon. The aim of this
study was to assess radiological features of SSc patients
with polyarthritis.
Methods
Clinical records of 60 SSc patients fulfilled the American
college of rheumatology classification criteria [2], admit-
ted to rheumatology department between 1981 and 2007
were reviewed. We included only patients with 4 or more
clinical synovitis (joint swelling and/or increase in
warmth). In all patients, we assessed at presentation cuta-
neous SSc subtype as defined by Leroy et al [3] (limited
disease when skin involvement was distal to the elbow/
knees, diffuse disease when the trunk was involved), dis-
ease duration calculated from the first symptom attribut-
able to SSc and visceral involvement defined by the
following means: heart (clinical examination, electrocar-
diogram and if necessary echocardiography), lung (dysp-
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nea, pulmonoray function test, chest radiograph and if
necessary computed tomography), kidney (urine analysis,
BUN, and serum creatinine level), gastrointestinal tract
(dysphagia, oesophageal manometry). The serological
status of the patients for rheumatoid factor was performed
by waaler rose test and latex agglutination test (cut-off
level 1/40), antinuclear antibodies (ANA) was determined
by indirect immunofluorescent technique on HEp-2 cells
(cut-off level : 1/40), and anti DNA topoisomerase I anti-
bodies (Anti-Scl 70) by enzyme-linked immunosorbent
assay (cut-off level, 20 EU/ml). Radiographs of hands and
feet at presentation, were read by 2 independent observ-
ers. The interobserver coefficient of variability was 0,1.
Three radiological patterns of abnormalities of joints (ero-
sion: interruption of the cortical surface; space narrowing:
focal or diffuse joint narrowing), bone (radiological dem-
ineralisation: juxta-articular or generalised osteoporosis;
bone resorption), and soft tissue (calcifications) were
assessed.
Statistical analysis was carried out with the student's test
for continuous data and chi square test for categorical
data. Multiple logistic regression was used to analyse pre-
dictor variables as age, disease duration and erythrocyte
sedimentation rate (ESR). Differences were considered
significant when p < 0,05
Results
At presentation, 46 out of 60 SSc patients had 4 or more
synovitis and were included in the study. Most of SSc
patients were women (female/male ratio 8,2) with a mean
age of 41 ± 14,2 (SD) years (median, 38.5 years) and a dis-
ease duration of 10,5 ± 6,5 years (median, 10 years). There
were 16 cases (35%) with limited scleroderma and 30
cases (65%) with diffuse scleroderma. The prevalence of
the different organs and systems involved were as follows:
Lung: 57%, Gastro-intestinal tract: 37%, heart: 17%, kid-
ney: 4%. Inactive digital ulcers were seen in 15% of cases
(see table 1).
Twelve patients had overlap syndromes: rheumatoid
arthritis, 2 cases; systemic lupus erythematosus, 3 cases,
polymyositis, 3 cases, sjögren syndrome, 4 cases.
For the serological status of the patients, SSc patients were
ANA positive in 62%, antitopoisomerase I antibodies
were positive in 33%. Rheumatoid factor was positive in
31%. when we compared the age (43,3 ± 14,1 vs 39,8 ±
14,3; p = 0,4) and disease duration (11,2 ± 7,3 versus 9,1
± 4,6; p = 0,2) of SSc patients divided in limited and dif-
fuse subset no difference emerged.
Juxtaarticular demineralization was detected in 17
patients (37%), distal phalange resorption in 8 patients
(18%) and extra articular calcifications in 5 patients
(12%). Radiological changes seen in our SSc patients are
summarized in the table 2. The more prevalent radiologi-
cal patterns of SSc patients are illustrated in figures 1, 2, 3,
4.
At presentation, the prevalence of radiological foot abnor-
malities was lower than that of hands (26% vs 79%, p <
0,001), whereas no significant difference was detected in
the prevalence of joint space narrowing (5% of the feet vs
33% of the hands; p = 0.3), erosion (12% of the feet ver-
X-ray of hands showing Figure 1
X-ray of hands showing. - Erosion of the fourth and the fifth 
proximal inter phalangeal joint on the left hand. - Terminal 
phalangeal tuft resorption (arrow).
Table 1: Characteristics of systemic sclerosis (SSc) patients
Characteristics of patients SSc patients
Sex: female/male 41/5
Mean age (years) 41 ± 14,2
Mean duration of disease 
(years)
10,5 ± 6,5
SSc subtype
Diffuse systemic sclerosis 30 (65%)
Limited systemic sclerosis 16 (35%)
Peripheral vascular (inactive 
Digital ulcers)
7 (15%)
Organ involvement
Lung involvment 25 (57%)
Gastro-intestinal involvement 17 (37%)
Heart involvement 8 (17%)
Kidney involvement 2(4,3%)
Positive rheumatoid factor 12(31%)
Positive antinuclear 
antibodies
24 (62%)
Antitopoisomerase I 15 (33%)
Values are presented as mean ± SD and n(%)
SSc: systemic sclerosisBMC Public Health 2007, 7:260 http://www.biomedcentral.com/1471-2458/7/260
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sus 31% of the hand; p = 0.18) and bone demineraliza-
tion (5% of the feet versus 33% of the hands; p = 0,29).
We found no significant difference between patients with
(n = 24) and without erosive arthropathy (Joint space nar-
rowing and/or erosion) (n = 22) in terms of cutaneous
subtype, organ involvement, calcinosis, presence of rheu-
matoid factor, ANA, Anti-topoisomerase antibodies (see
table 3). In multiple logistic regression, age of patients >
38 years, disease duration longer than 10 years and ESR
levels > 30 mm/h at presentation were risk factors but not
significant association with erosions emerged (see table 4)
Discussion
This study analyzed SSc patients with polyarthritis that
has been observed in 46 out of 60 cases. This result is in
agreement with Misra et al [4] who had documented clin-
ical synovitis and joint inflammation with imaging tech-
niques in 88% and 91%, respectively, of their SSc patients
with a current or past history of articular symptoms. Ero-
sive arthropathy was seen in 24/46 cases, is in agreement
with prevalence of other reports [1,5,6]. The erosions were
frequently atypical of rheumatoid arthritis, tended to be
small and discrete, reflecting the relatively non invasive
nature of the synovium in SSc. Histological studies have
shown mild proliferation and fibrosis without pannus
Table 3: Comparison between clinical and serological features of 
SSc patients with and without joint erosions
Erosive 
arthropathy N 
= 24 (%)
Non erosive 
arthropathy N 
= 22 (%)
P*
SSc subtype
Diffuse SSc 77,5 51,8 0,2
Limited SSc 22,5 48,2 0,3
Digital ulcers 13 18 0,5
Calcinosis 41 8 0 , 1
Organ 
involvement
Lung 
disease
58 50 0,5
Kidney 
involvement
441
Heart 
involvement
21 14 0,5
Gastro-
intestinal 
involvement
32 42 0,9
Associated 
connectivitis
21 30 0,4
RA 8 0 0,1
SLE 4 9 0,6
Sjögren's 
Syndrome
0 18 0,08
Polymyositi
s
85 0 , 4
Positive 
rheumatoid 
factor
33 18 0,2
Positive 
antinuclear 
antibodies
46 60 0,9
Anti 
topoisomera
se I antibody
45 0 , 9
Values are %
*Comparison between two groups carried out by chi-square test,
RA: rheumatoid arthritis, SLE: systemic lupus erythematosus
Table 2: Radiological abnormalities of the hands, wrists and feet 
in systemic sclerosis (SSc) patients
Radiological abnormalities Systemic patients n = 46
Radiological abnormalities 
in the hand
Bone demineralization 33%
Joint space narrowing 15(33%)
MCP 3
PIP 11
DIP 2
Radiocarpal 7
Joint erosions 14(31%)
MCP 4
PIP 10
DIP 1
Radiocarpal 7
Ulnar styloid erosions 1(2%)
Radiological abnormalities 
in the foot
Bone demineralization 5%
Joint space narrowing 2 (5%)
MTP 1
Ankle 1
Joint erosion 5 (12%)
MTP 3
Talo-navicular joint 2
Terminal phalangeal tuft 
resorption
8 (18%)
Calcinosis 5(12%)
Values are n (%)
DIP: distal interphalangeal joint, MCP: metacarpophalangeal joint, 
PIP: proximal interphalangeal joint. MTP: metatarsophalangeal joint
Table 4: Correlation between some clinical patients 
characteristics and erosive changes in systemic sclerosis patients
Variable Odds Ratio 
(OR)
95% 
Confidence 
interval
P*
Age > 38 years 1,15 0,33–3,9 0,8
Disease 
duration > 10 
years
2,1 0,61–7,3 0,2
ESR > 30 mm 3 0,8–11,8 0,1
* Multiple logistic regression
ESR: erythrocyte sedimentation rateBMC Public Health 2007, 7:260 http://www.biomedcentral.com/1471-2458/7/260
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formation [7]. The cause of erosions in SSc remains
unclear and has been hypotesized a role of traction of ten-
dons on demineralised bone or ischemic bone resorption
[8,9]. Rabinowitz et al [10] reviewed the hand and wrist x-
rays of 24 patients with scleroderma. All had mild arthral-
gia or arthritis, and bone erosions were seen in 13
patients. The x-rays of 7 patients showed many features in
common with rheumatoid arthritis.
A marked erosive lesions resembling rheumatoid arthritis
may be observed in SSc patients [10]. In our study, the
diagnosis of scleroderma in the two cases who had
changes resembling those seen in rheumatoid arthritis
was not in doubt. They had a proximal scleroderma
changes considered to be the major manifestation of this
disorder. An overlap syndrome can not be excluded in
those cases. One third of our patients had positive test for
rheumatoid factor. This may occur in 30 % of patients
with scleroderma. Clark et al [11] found a correlation
between inflammatory synovial biopsy appearances and
the presence of rheumatoid factor in the serum or synovial
fluid. Kellgren and Ball [12] believed that high titres of
rheumatoid factor tended to occur in patients with pro-
eminent articular features. However this was not con-
firmed by Rodnan [13] in his study of 29 patients.
Recently Ingegnoli et al [14] found in 75 SSc patients a sta-
tistically significant association between the positivity of
anti cyclic citrullinated peptide antibodies (anti CCP) and
the presence of arthritis and marginal erosions. This may
help to define the diagnosis of overlap syndrome SSc/RA
and to facilitate diagnosis and appropriate treatment. Two
thirds of our patients had ANA positivity. Prevalence of
ANA in our series is lower than that reported in European
studies [6,15], whereas is in agreement with a recent a
Moroccan study [16]. We hypothesized that this may be
due to etnic variability.
X-ray of a left foot Figure 4
X-ray of a left foot. Erosive lesion in the first metatarso-
phalangeal joint, and subluxation and erosion of the second 
proximal inter phalangeal joint similar to psoriatic arthritis.
X-ray of hand showing: a small and discrete lesion in the  fourth metacarpo-phalangeal joint similar to early rheuma- toïd arthritis Figure 2
X-ray of hand showing: a small and discrete lesion in the 
fourth metacarpo-phalangeal joint similar to early rheuma-
toïd arthritis.
X-ray of hands showing a joint space narrowing in the proxi- mal inter phalangeal joint similar to erosive osteoarthritis Figure 3
X-ray of hands showing a joint space narrowing in the proxi-
mal inter phalangeal joint similar to erosive osteoarthritis.BMC Public Health 2007, 7:260 http://www.biomedcentral.com/1471-2458/7/260
Page 5 of 6
(page number not for citation purposes)
In our study, the more frequent changes were joint space
narrowing in PIP, that may be due to deformities of the
fingers caused by soft tissue contractures. Instead the joint
space narrowing of DIP joints were uncommon in con-
trast with Avouac et al [17] who described a higher fre-
quency of changes. Many of those cases were associated
with erosive changes and a radiological picture compati-
ble with erosive osteoarthritis. However, the DIP lesions
appear to be both deeper and more destructive than the
usual picture of erosive osteoarthritis. Selective erosions
of the first carpo-metacarpal joint has been described in
scleroderma [9,18]. In this study, the PIP joint and radio-
carpal joint were the most common site for erosions. An
interesting finding in our patients was the difference
between Feet and hand radiologic abnormalities that in
agreement with La Montagna findings in his longitudinal
study of 100 patients [6] confirms that the foot involve-
ment is less frequent. Hand changes is generally observed
at disease onset and remained nearly unchanged over
time, foot changes began later and worsened with ongo-
ing disease [6]. This contrast with rheumatoid arthritis
patients in whom radiologic features occur earlier in the
feet than in the hands, although the rate of damage
progress similarly.
In Previous reported data, destructive arthropathy was
associated to high C reactive proteine concentration (> 10
mg/l) suggesting that inflammatory articular involvement
may partly account for the unusual inflammatory syn-
drome observed in SSc patients [17]. In our study, no rela-
tion was found between the occurrence of destructive
arthropathy and age, organ involvement, calcinosis, asso-
ciated connectivitis, presence of rheumatoid factor and
antinuclear antibodies. In the multiple logistic regression
analysis, higher ESR age > 38 years or disease duration >
10 years, were risk factors for occurrence of erosions but a
not significant relationship was found, indicating that
probably other factors may be considered.
Our study has many limitations; it was a retrospective
study and analyzed a small number of patients. Large
studies including patients with scleroderma and erosive
arthropathy are required to confirm our results.
Conclusion
We documented a high frequency of clinical synovitis in
our SSc patients, and a relatively low prevalence of ANA in
Moroccan SSc patients. Other studies on SSc patients with
arthropathy are needed to confirm our results.
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